4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-015318
Options or other derivatives
- Chief Scientific Officer acquired 66,650 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Garfield Alastair Chief Scientific Officer | 2025-02-14 | Grant or award · Restricted Stock Units | +26,650 | 26,650 | D | ||
| Garfield Alastair Chief Scientific Officer | 2025-02-14 | Grant or award · Stock Options (Right to Buy) | +40,000 | 40,000 | D | ||
Loading xslF345X05/tm257103-2_4seq1.xml…